Copyright Reports & Markets. All rights reserved.

Global Pharmacovigilance and Drug Safety Software Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Pharmacovigilance and Drug Safety Software Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Pharmacovigilance and Drug Safety Software Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Adverse Event Reporting Software
    • 1.4.3 Drug Safety Audits Software
    • 1.4.4 Issue Tracking Software
    • 1.4.5 Fully Integrated Software
  • 1.5 Market by Application
    • 1.5.1 Global Pharmacovigilance and Drug Safety Software Market Share by Application: 2020 VS 2026
    • 1.5.2 Pharma and Biotech Companies
    • 1.5.3 Contract Research Organizations (CROs)
    • 1.5.4 Business Process Outsourcing (BPO) Firms
    • 1.5.5 Pharmacovigilance Service Providers
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Pharmacovigilance and Drug Safety Software Market Perspective (2015-2026)
  • 2.2 Global Pharmacovigilance and Drug Safety Software Growth Trends by Regions
    • 2.2.1 Pharmacovigilance and Drug Safety Software Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Pharmacovigilance and Drug Safety Software Historic Market Share by Regions (2015-2020)
    • 2.2.3 Pharmacovigilance and Drug Safety Software Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Pharmacovigilance and Drug Safety Software Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Pharmacovigilance and Drug Safety Software Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Pharmacovigilance and Drug Safety Software Players by Market Size
    • 3.1.1 Global Top Pharmacovigilance and Drug Safety Software Players by Revenue (2015-2020)
    • 3.1.2 Global Pharmacovigilance and Drug Safety Software Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Pharmacovigilance and Drug Safety Software Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Pharmacovigilance and Drug Safety Software Market Concentration Ratio
    • 3.2.1 Global Pharmacovigilance and Drug Safety Software Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Pharmacovigilance and Drug Safety Software Revenue in 2019
  • 3.3 Pharmacovigilance and Drug Safety Software Key Players Head office and Area Served
  • 3.4 Key Players Pharmacovigilance and Drug Safety Software Product Solution and Service
  • 3.5 Date of Enter into Pharmacovigilance and Drug Safety Software Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Pharmacovigilance and Drug Safety Software Historic Market Size by Type (2015-2020)
  • 4.2 Global Pharmacovigilance and Drug Safety Software Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Pharmacovigilance and Drug Safety Software Market Size by Application (2015-2020)
  • 5.2 Global Pharmacovigilance and Drug Safety Software Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Pharmacovigilance and Drug Safety Software Market Size (2015-2020)
  • 6.2 Pharmacovigilance and Drug Safety Software Key Players in North America (2019-2020)
  • 6.3 North America Pharmacovigilance and Drug Safety Software Market Size by Type (2015-2020)
  • 6.4 North America Pharmacovigilance and Drug Safety Software Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Pharmacovigilance and Drug Safety Software Market Size (2015-2020)
  • 7.2 Pharmacovigilance and Drug Safety Software Key Players in Europe (2019-2020)
  • 7.3 Europe Pharmacovigilance and Drug Safety Software Market Size by Type (2015-2020)
  • 7.4 Europe Pharmacovigilance and Drug Safety Software Market Size by Application (2015-2020)

8 China

  • 8.1 China Pharmacovigilance and Drug Safety Software Market Size (2015-2020)
  • 8.2 Pharmacovigilance and Drug Safety Software Key Players in China (2019-2020)
  • 8.3 China Pharmacovigilance and Drug Safety Software Market Size by Type (2015-2020)
  • 8.4 China Pharmacovigilance and Drug Safety Software Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Pharmacovigilance and Drug Safety Software Market Size (2015-2020)
  • 9.2 Pharmacovigilance and Drug Safety Software Key Players in Japan (2019-2020)
  • 9.3 Japan Pharmacovigilance and Drug Safety Software Market Size by Type (2015-2020)
  • 9.4 Japan Pharmacovigilance and Drug Safety Software Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Pharmacovigilance and Drug Safety Software Market Size (2015-2020)
  • 10.2 Pharmacovigilance and Drug Safety Software Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Pharmacovigilance and Drug Safety Software Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Pharmacovigilance and Drug Safety Software Market Size by Application (2015-2020)

11 India

  • 11.1 India Pharmacovigilance and Drug Safety Software Market Size (2015-2020)
  • 11.2 Pharmacovigilance and Drug Safety Software Key Players in India (2019-2020)
  • 11.3 India Pharmacovigilance and Drug Safety Software Market Size by Type (2015-2020)
  • 11.4 India Pharmacovigilance and Drug Safety Software Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Pharmacovigilance and Drug Safety Software Market Size (2015-2020)
  • 12.2 Pharmacovigilance and Drug Safety Software Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Pharmacovigilance and Drug Safety Software Market Size by Type (2015-2020)
  • 12.4 Central & South America Pharmacovigilance and Drug Safety Software Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 AB Cube
    • 13.1.1 AB Cube Company Details
    • 13.1.2 AB Cube Business Overview
    • 13.1.3 AB Cube Pharmacovigilance and Drug Safety Software Introduction
    • 13.1.4 AB Cube Revenue in Pharmacovigilance and Drug Safety Software Business (2015-2020))
    • 13.1.5 AB Cube Recent Development
  • 13.2 Sparta Systems, Inc.
    • 13.2.1 Sparta Systems, Inc. Company Details
    • 13.2.2 Sparta Systems, Inc. Business Overview
    • 13.2.3 Sparta Systems, Inc. Pharmacovigilance and Drug Safety Software Introduction
    • 13.2.4 Sparta Systems, Inc. Revenue in Pharmacovigilance and Drug Safety Software Business (2015-2020)
    • 13.2.5 Sparta Systems, Inc. Recent Development
  • 13.3 Oracle Corporation
    • 13.3.1 Oracle Corporation Company Details
    • 13.3.2 Oracle Corporation Business Overview
    • 13.3.3 Oracle Corporation Pharmacovigilance and Drug Safety Software Introduction
    • 13.3.4 Oracle Corporation Revenue in Pharmacovigilance and Drug Safety Software Business (2015-2020)
    • 13.3.5 Oracle Corporation Recent Development
  • 13.4 EXTEDO GmbH
    • 13.4.1 EXTEDO GmbH Company Details
    • 13.4.2 EXTEDO GmbH Business Overview
    • 13.4.3 EXTEDO GmbH Pharmacovigilance and Drug Safety Software Introduction
    • 13.4.4 EXTEDO GmbH Revenue in Pharmacovigilance and Drug Safety Software Business (2015-2020)
    • 13.4.5 EXTEDO GmbH Recent Development
  • 13.5 Ennov Solutions, Inc.
    • 13.5.1 Ennov Solutions, Inc. Company Details
    • 13.5.2 Ennov Solutions, Inc. Business Overview
    • 13.5.3 Ennov Solutions, Inc. Pharmacovigilance and Drug Safety Software Introduction
    • 13.5.4 Ennov Solutions, Inc. Revenue in Pharmacovigilance and Drug Safety Software Business (2015-2020)
    • 13.5.5 Ennov Solutions, Inc. Recent Development
  • 13.6 ArisGlobal
    • 13.6.1 ArisGlobal Company Details
    • 13.6.2 ArisGlobal Business Overview
    • 13.6.3 ArisGlobal Pharmacovigilance and Drug Safety Software Introduction
    • 13.6.4 ArisGlobal Revenue in Pharmacovigilance and Drug Safety Software Business (2015-2020)
    • 13.6.5 ArisGlobal Recent Development
  • 13.7 Oracle Corporation
    • 13.7.1 Oracle Corporation Company Details
    • 13.7.2 Oracle Corporation Business Overview
    • 13.7.3 Oracle Corporation Pharmacovigilance and Drug Safety Software Introduction
    • 13.7.4 Oracle Corporation Revenue in Pharmacovigilance and Drug Safety Software Business (2015-2020)
    • 13.7.5 Oracle Corporation Recent Development
  • 13.8 United BioSource Corporation
    • 13.8.1 United BioSource Corporation Company Details
    • 13.8.2 United BioSource Corporation Business Overview
    • 13.8.3 United BioSource Corporation Pharmacovigilance and Drug Safety Software Introduction
    • 13.8.4 United BioSource Corporation Revenue in Pharmacovigilance and Drug Safety Software Business (2015-2020)
    • 13.8.5 United BioSource Corporation Recent Development
  • 13.9 Online Business Applications, Inc.
    • 13.9.1 Online Business Applications, Inc. Company Details
    • 13.9.2 Online Business Applications, Inc. Business Overview
    • 13.9.3 Online Business Applications, Inc. Pharmacovigilance and Drug Safety Software Introduction
    • 13.9.4 Online Business Applications, Inc. Revenue in Pharmacovigilance and Drug Safety Software Business (2015-2020)
    • 13.9.5 Online Business Applications, Inc. Recent Development
  • 13.10 UMBRA Global LLC
    • 13.10.1 UMBRA Global LLC Company Details
    • 13.10.2 UMBRA Global LLC Business Overview
    • 13.10.3 UMBRA Global LLC Pharmacovigilance and Drug Safety Software Introduction
    • 13.10.4 UMBRA Global LLC Revenue in Pharmacovigilance and Drug Safety Software Business (2015-2020)
    • 13.10.5 UMBRA Global LLC Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Pharmacovigilance and Drug Safety Software market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pharmacovigilance and Drug Safety Software market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    AB Cube
    Sparta Systems, Inc.
    Oracle Corporation
    EXTEDO GmbH
    Ennov Solutions, Inc.
    ArisGlobal
    Oracle Corporation
    United BioSource Corporation
    Online Business Applications, Inc.
    UMBRA Global LLC

    Market segment by Type, the product can be split into
    Adverse Event Reporting Software
    Drug Safety Audits Software
    Issue Tracking Software
    Fully Integrated Software
    Market segment by Application, split into
    Pharma and Biotech Companies
    Contract Research Organizations (CROs)
    Business Process Outsourcing (BPO) Firms
    Pharmacovigilance Service Providers

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now